oxatomide and hydroxyzine

oxatomide has been researched along with hydroxyzine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
de Mol, NJ; Fischer, MJ; Horbach, DA; Janssen, LH; Paulussen, JJ; Roelofsen, EP; van Miltenburg, JC1
Arita, K; Natsuga, K; Shimizu, H; Shimizu, T; Tomizawa, K; Ujiie, H1

Other Studies

3 other study(ies) available for oxatomide and hydroxyzine

ArticleYear
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Inhibition of mediator release in RBL-2H3 cells by some H1-antagonist derived anti-allergic drugs: relation to lipophilicity and membrane effects.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1995, Volume: 44, Issue:2

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Antigens; Astemizole; beta-N-Acetylhexosaminidases; Calorimetry, Differential Scanning; Cell Membrane; Cetirizine; Histamine H1 Antagonists; Hydroxyzine; Leukemia, Basophilic, Acute; Mast Cells; Meclizine; Piperazines; Rats; Receptors, IgE; Signal Transduction; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1995
Severe cholinergic urticaria successfully treated with scopolamine butylbromide in addition to antihistamines.
    Clinical and experimental dermatology, 2006, Volume: 31, Issue:4

    Topics: Adult; Butylscopolammonium Bromide; Drug Therapy, Combination; Exercise; Famotidine; Histamine H1 Antagonists; Histamine H2 Antagonists; Hot Temperature; Humans; Hydroxyzine; Male; Muscarinic Antagonists; Piperazines; Urticaria

2006